<DOC>
	<DOCNO>NCT00266318</DOCNO>
	<brief_summary>The main purpose study evaluate safety tolerability combination therapy daily interferon alfacon-1 ( Infergen , CIFN ) high dosage ( 24 mcg ) ribavirin ( base body weight ) 48 week HCV genotype 1 infected subject , non-responders previous pegylated interferon alfa plus ribavirin therapy . This open-label , multicenter study . All subject receive Infergen 24 mcg administer injection daily plus ribavirin 800-1400 mg ( base body weight ) administer mouth daily 48 week * If 5 first 10 subject tolerate 24 mcg daily dosage Infergen week 4 , determine principal investigator , dosage Infergen change 15 mcg administer injection daily plus ribavirin 800-1400 mg ( base body weight ) administer mouth daily 48 week</brief_summary>
	<brief_title>Study High Dosage CIFN Plus RBV HCV Genotype 1 Infected Patients Who Are Nonresponders Prior Therapy</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Interferon alfacon-1</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>Must document failure respond past treatment Pegylated IFN + RBV . Failure respond past treatment define positive HCV RNA 12 week less 2 log drop baseline ; OR positive HCV RNA great 2 log drop baseline week 12 must receive 24 week therapy still positive HCV RNA Must tolerate previous hepatitis C therapy Must hepatitis C therapy 3 month prior study participation Must liver biopsy within past 5 year Decompensated liver disease Laboratory abnormality per protocol HIV+ Autoimmune disease Unstable deteriorate cardiovascular cerebrovascular disease History seizures past 5 year Alcohol drug abuse past year Pregnant lactating woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Hepatitis C Nonresponder</keyword>
	<keyword>Genotype 1</keyword>
	<keyword>Interferon Alfacon-1</keyword>
	<keyword>Consensus Interferon</keyword>
	<keyword>CIFN</keyword>
	<keyword>Infergen</keyword>
	<keyword>Ribavirin</keyword>
</DOC>